Person:
ÇINAR, TUĞBA

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

ÇINAR

First Name

TUĞBA

Name

Filters

2020 - 20222
Reset filters

Settings

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Clinical manifestations of adult-onset still's disease
    (Doc Design Informatics Co Ltd, 2020-08-01) Semet, Cihan; Şişman, Ayşe Sena; Çınar, Tuğba; Anaç, İsmail; Pehlivan, Yavuz; Akalın, Halis; SEMET, CİHAN; ŞİŞMAN, AYŞE SENA; ÇINAR, TUĞBA; ANAÇ, İSMAİL; PEHLİVAN, YAVUZ; AKALIN, EMİN HALİS; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; 0000-0001-7530-1279; 0000-0003-2210-820X; AEA-4817-2022; GOI-2416-2022; IQX-9185-2023; CBL-8711-2022; IRX-3951-2023; AAU-8952-2020
  • No Thumbnail Available
    Publication
    A rare presentation of cat-scratch disease: A case report with neuroretinitis and review of cases reported from Turkey
    (Doc Design Informatics Co Ltd, 2022-09-01) Çınar, Tuğba; ÖNAL, UĞUR; ÇINAR, TUĞBA; YALÇINBAYIR, ÖZGÜR; Yalçınbayır, Özgür; Akalın, Halis; AKALIN, EMİN HALİS; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Göz Hastalıkları Anabilim Dalı.; 0000-0001-6194-3254; 0000-0002-7311-5277; 0000-0001-7530-1279; ACQ-7832-2022; JCO-3678-2023; AAU-8952-2020; IYJ-9408-2023
    Neuroretinitis is a rare presentation of cat-scratch disease caused by Bartonella henselae. In this case report, we aimed to describe a 46-year-old male patient who presented with acute visual loss and was diagnosed as neuroretinitis. Fundus examination showed evidence of optic disc edema, macular star, and peripapillary hemorrhagia. The serological tests were positive for Bartonella with both IgM and IgG titers as 1/320. He was successfully treated with doxycycline for eight weeks. Both clinical and serological improvements were observed during the follow-up.